ISoOR is a premier resource for the latest information on liver organoids, providing researchers with crucial insights into this vital area of study. ISoOR organizes conferences focused on liver organoid research, fostering collaboration and knowledge exchange among experts. Additionally, ISoOR features Research Highlights that summarize key findings and breakthroughs, ensuring the scientific community stays informed about advancements in liver organoid technology.
[Cell Reports Medicine]Liver organoid reveals that downregulation of IL32 may be beneficial for preventing and treating non-alcoholic fatty liver disease (NAFLD).
[Hepatology] The study developed a new liver disease model by co-culturing hPSC-derived liver organoids and macrophages. This approach led to the transformation of macrophages into Kupffer-like cells ...
[The EMBO Journal] The study developed a human liver organoid model for MASLD, testing the effects of oleic acid, palmitic acid, and TGF-β1. Findings show all three induce inflammation, but only TGF-...
[mBio] This research utilizes an adult stem cell-derived liver organoid system to elucidate the progression of late-stage liver disease caused by Hepatitis C virus (HCV) infection. By studying liver o...
[Nat Biotechnol] The human fetal liver cell-like organ is used to reveal the pathogenic mechanisms of non-alcoholic fatty liver disease, contributing to the study of the etiology and drug targets for ...